log2LFQ-inputed-column-log2FC.xlsx

syn53445520

Created By Julia Meyer jmeyer1

studyId: syn51133946
studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial
initiative: DHART-SPORE Project 3
fundingAgency: NIH-NCI

log2LFQ-inputed-column-log2FC.xlsx page is loading…